Tenax Therapeutics is trading at $2.15, 10.57% up on September 8, 2026, with no clear company-specific announcement explaining the move.

  • Scheduled to present at the Cantor Global Healthcare Conference on September 9; the event was announced September 1 and does not directly explain today’s gain.
  • Broader markets are lower, making the advance appear isolated and speculative rather than driven by overall market sentiment.